Search Results

There are 3520 results for: content related to: Long-term entecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis B

  1. You have free access to this content
    JSH Guidelines for the Management of Hepatitis B Virus Infection

    Hepatology Research

    Volume 44, Issue S1, January 2014, Pages: 1–58, Drafting Committee for Hepatitis Management Guidelines and the Japan Society of Hepatology

    Version of Record online : 7 JAN 2014, DOI: 10.1111/hepr.12269

  2. Efficacy of entecavir treatment for lamivudine-resistant hepatitis B over 3 years: Histological improvement or entecavir resistance?

    Journal of Gastroenterology and Hepatology

    Volume 24, Issue 3, March 2009, Pages: 429–435, Yoshiyuki Suzuki, Fumitaka Suzuki, Yusuke Kawamura, Hiromi Yatsuji, Hitomi Sezaki, Tetsuya Hosaka, Norio Akuta, Masahiro Kobayashi, Satoshi Saitoh, Yasuji Arase, Kenji Ikeda, Mariko Kobayashi, Yuzo Miyakawa and Hiromitsu Kumada

    Version of Record online : 15 FEB 2009, DOI: 10.1111/j.1440-1746.2008.05760.x

  3. You have free access to this content
    HBV Trials and Treatments

    Hepatology

    Volume 58, Issue S1, October 2013, Pages: 647A–705A,

    Version of Record online : 15 OCT 2013, DOI: 10.1002/hep.26856

  4. You have free access to this content
    Severe lactic acidosis during treatment of chronic hepatitis B with entecavir in patients with impaired liver function

    Hepatology

    Volume 50, Issue 6, December 2009, Pages: 2001–2006, Christian M. Lange, Jörg Bojunga, Wolf Peter Hofmann, Katrin Wunder, Ulrike Mihm, Stefan Zeuzem and Christoph Sarrazin

    Version of Record online : 29 SEP 2009, DOI: 10.1002/hep.23346

  5. Antiviral effect of entecavir in nucleos(t)ide analogue-naïve and nucleos(t)ide analogue-experienced chronic hepatitis B patients without virological response at week 24 or 48 of therapy

    Journal of Viral Hepatitis

    Volume 21, Issue 8, August 2014, Pages: e55–e64, Chien-Hung Chen, Tsung-Hui Hu, Chao-Hung Hung, Jing-Houng Wang, Sheng-Nan Lu and Chuan-Mo Lee

    Version of Record online : 28 APR 2014, DOI: 10.1111/jvh.12239

  6. You have free access to this content
    Randomized, controlled trial of entecavir versus placebo in children with hepatitis B envelope antigen–positive chronic hepatitis B

    Hepatology

    Volume 63, Issue 2, February 2016, Pages: 377–387, Maureen M. Jonas, Mei-Hwei Chang, Etienne Sokal, Kathleen B. Schwarz, Deirdre Kelly, Kyung Mo Kim, Simon C. Ling, Philip Rosenthal, Dumitru Oraseanu, Laurie Reynolds, Alexandra Thiry and Peter Ackerman

    Version of Record online : 16 OCT 2015, DOI: 10.1002/hep.28015

  7. You have free access to this content
    Entecavir treatment for up to 5 years in patients with hepatitis B e antigen–positive chronic hepatitis B

    Hepatology

    Volume 51, Issue 2, February 2010, Pages: 422–430, Ting-Tsung Chang, Ching-Lung Lai, Seung Kew Yoon, Samuel S. Lee, Henrique Sergio M. Coelho, Flair Jose Carrilho, Fred Poordad, Waldemar Halota, Yves Horsmans, Naoky Tsai, Hui Zhang, Daniel J. Tenney, Ricardo Tamez and Uchenna Iloeje

    Version of Record online : 4 JAN 2010, DOI: 10.1002/hep.23327

  8. Do different lamivudine-resistant hepatitis B genotypes carry the same risk of entecavir resistance?

    Journal of Medical Virology

    Volume 85, Issue 1, January 2013, Pages: 26–33, Guan Huei Lee, Myat Oo Aung, Yock Young Dan, Yin Mei Lee, Belinda Mak, How Cheng Low, Kieron Lim, Maung Aye Thwin, Poh Seng Tan and Seng Gee Lim

    Version of Record online : 28 SEP 2012, DOI: 10.1002/jmv.23392

  9. Entecavir Pharmacokinetics, Safety, and Tolerability After Multiple Ascending Doses in Healthy Subjects

    The Journal of Clinical Pharmacology

    Volume 46, Issue 11, November 2006, Pages: 1250–1258, Dr Jing-He Yan, Mr Marc Bifano, Mr Steven Olsen, Dr Robert A. Smith, Dr Duxi Zhang, Dr Dennis M. Grasela and Dr Frank LaCreta

    Version of Record online : 8 MAR 2013, DOI: 10.1177/0091270006293304

  10. Efficacy of switching to entecavir monotherapy in Japanese lamivudine-pretreated patients

    Journal of Gastroenterology and Hepatology

    Volume 25, Issue 5, May 2010, Pages: 892–898, Fumitaka Suzuki, Norio Akuta, Yoshiyuki Suzuki, Hiromi Yatsuji, Hitomi Sezaki, Yasuji Arase, Miharu Hirakawa, Yusuke Kawamura, Tetsuya Hosaka, Masahiro Kobayashi, Satoshi Saitoh, Kenji Ikeda, Mariko Kobayashi, Sachiyo Watahiki and Hiromitsu Kumada

    Version of Record online : 30 OCT 2009, DOI: 10.1111/j.1440-1746.2009.06161.x

  11. You have free access to this content
    Entecavir therapy for lamivudine-refractory chronic hepatitis B: Improved virologic, biochemical, and serology outcomes through 96 weeks

    Hepatology

    Volume 48, Issue 1, July 2008, Pages: 99–108, Morris Sherman, Cihan Yurdaydin, Halis Simsek, Marcelo Silva, Yun-Fan Liaw, Vinod K. Rustgi, Hoel Sette, Naoky Tsai, Daniel J. Tenney, James Vaughan, Bruce Kreter and Robert Hindes

    Version of Record online : 8 JUN 2008, DOI: 10.1002/hep.22323

  12. Efficacy and safety of entecavir in lamivudine-refractory patients with chronic hepatitis B: Randomized controlled trial in Japanese patients

    Journal of Gastroenterology and Hepatology

    Volume 23, Issue 9, September 2008, Pages: 1320–1326, Fumitaka Suzuki, Joji Toyoda, Yoshiaki Katano, Michio Sata, Mitsuhiko Moriyama, Fumio Imazeki, Masayoshi Kage, Taku Seriu, Masao Omata and Hiromitsu Kumada

    Version of Record online : 28 JUN 2008, DOI: 10.1111/j.1440-1746.2008.05455.x

  13. You have free access to this content
    Entecavir treatment reduces hepatic events and deaths in chronic hepatitis B patients With liver cirrhosis

    Hepatology

    Volume 58, Issue 5, November 2013, Pages: 1537–1547, Grace Lai-Hung Wong, Henry Lik-Yuen Chan, Christy Wing-Hin Mak, Stanley King-Yeung Lee, Zoe Man-Yi Ip, Andrew Ting-Ho Lam, Henry Wing-Hang Iu, Joyce May-Sum Leung, Jennifer Wing-Yan Lai, Angeline Oi-Shan Lo, Hoi-Yun Chan and Vincent Wai-Sun Wong

    Version of Record online : 30 SEP 2013, DOI: 10.1002/hep.26301

  14. You have free access to this content
    Poster Sessions

    Hepatology

    Volume 58, Issue S1, October 2013, Pages: 92A–207A,

    Version of Record online : 1 OCT 2013, DOI: 10.1002/hep.26726

  15. Changes of HBsAg and HBV DNA levels in Chinese chronic hepatitis B patients after 5 years of entecavir treatment

    Journal of Gastroenterology and Hepatology

    Volume 29, Issue 5, May 2014, Pages: 1028–1034, Wai-Kay Seto, Yuk-Fai Lam, James Fung, Danny Ka-Ho Wong, Fung-Yu Huang, Ivan Fan-Ngai Hung, Ching-Lung Lai and Man-Fung Yuen

    Version of Record online : 21 APR 2014, DOI: 10.1111/jgh.12476

  16. Hepatocellular carcinoma risk in HBeAg-negative chronic hepatitis B patients with or without cirrhosis treated with entecavir: HepNet.Greece cohort

    Journal of Viral Hepatitis

    Volume 22, Issue 2, February 2015, Pages: 120–127, G. V. Papatheodoridis, S. Manolakopoulos, G. Touloumi, G. Nikolopoulou, M. Raptopoulou-Gigi, C. Gogos, I. Vafiadis-Zouboulis, D. Karamanolis, A. Chouta, A. Ilias, C. Drakoulis, K. Mimidis, I. Ketikoglou, E. Manesis, M. Mela, G. Hatzis, G. N. Dalekos and for the HepNet.Greece Study Group

    Version of Record online : 15 JUL 2014, DOI: 10.1111/jvh.12283

  17. A meta-analysis comparing the efficacy of entecavir and tenofovir for the treatment of chronic hepatitis B infection

    The Journal of Clinical Pharmacology

    Volume 55, Issue 3, March 2015, Pages: 288–297, Shan-Ru Zuo, Xiao-Cong Zuo, Chun-Jiang Wang, Yu-Tao Ma, Hao-Ye Zhang, Zuo-Jun Li, Li-Ying Song, Zhen-Zhen Deng and Shi-Kun Liu

    Version of Record online : 20 NOV 2014, DOI: 10.1002/jcph.409

  18. You have free access to this content
    Analysis of hepatitis B virus drug-resistant mutant haplotypes by ultra-deep pyrosequencing

    Clinical Microbiology and Infection

    Volume 18, Issue 10, October 2012, Pages: E404–E411, S.-Y. Ko, H.-B. Oh, C.-W. Park, H. C. Lee and J.-E. Lee

    Version of Record online : 3 JUL 2012, DOI: 10.1111/j.1469-0691.2012.03951.x

  19. You have free access to this content
    Undetectable HBV DNA at month 12 of entecavir treatment predicts maintained viral suppression and HBeAg-seroconversion in chronic hepatitis B patients at 3 years

    Alimentary Pharmacology & Therapeutics

    Volume 35, Issue 11, June 2012, Pages: 1326–1335, G. L.-H. Wong, V. W.-S. Wong, H.-Y. Chan, P. C.-H. Tse, J. Wong, A. M.-L. Chim, K. K.-L. Yiu, S. H.-T. Chu and H. L.-Y. Chan

    Version of Record online : 16 APR 2012, DOI: 10.1111/j.1365-2036.2012.05098.x

  20. Absence of a Pharmacokinetic Interaction Between Entecavir and Adefovir

    The Journal of Clinical Pharmacology

    Volume 47, Issue 10, October 2007, Pages: 1327–1334, Mr Marc Bifano, Dr Jing-He Yan, Dr Robert A. Smith, Dr Duxi Zhang, Dr Dennis M. Grasela and Dr Frank LaCreta

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270007304780